MARKET

CSBR

CSBR

Champions Oncolo
NASDAQ
5.79
-0.01
-0.17%
Closed 16:10 03/26 EDT
OPEN
5.80
PREV CLOSE
5.80
HIGH
5.85
LOW
5.75
VOLUME
8.10K
TURNOVER
0
52 WEEK HIGH
9.97
52 WEEK LOW
5.50
MARKET CAP
80.40M
P/E (TTM)
-34.7957
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CSBR last week (0316-0320)?
Weekly Report · 4d ago
Weekly Report: what happened at CSBR last week (0309-0313)?
Weekly Report · 03/16 10:03
Champions Oncology Balances Record Services With Margin Strain
TipRanks · 03/14 00:08
Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business
Seeking Alpha · 03/12 21:42
Champions Oncology Q3 revenue dips 3% 
Reuters · 03/12 20:29
Champions Oncology Non-GAAP EPS of $0.04, revenue of $16.6M
Seeking Alpha · 03/12 20:05
Champions Oncology Q3 Adj. EPS $0.04 Misses $0.09 Estimate, Sales $16.559M Miss $16.613M Estimate
Benzinga · 03/12 20:03
Earnings Scheduled For March 12, 2026
Benzinga · 03/12 11:11
More
About CSBR
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Webull offers Champions Oncology Inc stock information, including NASDAQ: CSBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSBR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSBR stock methods without spending real money on the virtual paper trading platform.